Thursday, February 12, 2015

Drea de Matteo to Guest Star on AGENTS OF S.H.I.E.L.D.


Marvel announced today that Drea de Matteo will guest star on AGENTS OF S.H.I.E.L.D. as Karla Faye Gideon. Here is what they had to say regarding her character: "a Gifted woman with a grudge to bear against S.H.I.E.L.D. who joins forces with Skye’s father, Cal."
What's interesting is that Karla Faye Gideon is a character from Daredevil: Redemption, but she didn't have powers in that comic. So they are clearly taking this character in a different direction on the show. Either way, Matteo is an awesome get for this show.

Here is the full press release from Marvel:
With the return of “Marvel’s Agents of S.H.I.E.L.D.” this March, the series has already added a new villain to face our heroes with Emmy-winning actress Drea de Matteo!

Matteo will play Karla Faye Gideon, a Gifted woman with a grudge to bear against S.H.I.E.L.D. who joins forces with Skye’s father, Cal.

“We’re thrilled to have Drea join us as yet another great villain to challenge our cast,” said Executive Producer and Marvel’s Head of Marvel Television, Jeph Loeb. “We relished the opportunity to work with her in such a menacing role.”

Matteo earned an Emmy for her role as Adriana La Cerva in “The Sopranos,” and since then has starred in series such as “Sons of Anarchy,” “Desperate Housewives,” and “Joey.”

"Marvel's Agents of S.H.I.E.L.D." is Executive Produced by Joss Whedon ("Marvel's The Avengers," "Buffy the Vampire Slayer"); Jed Whedon & Maurissa Tancharoen, ("Marvel's Agents of S.H.I.E.L.D." pilot co-writers, "Dollhouse," "Dr.Horrible's Sing-Along Blog"); Jeffrey Bell ("Angel," "Alias"); and Jeph Loeb (“Marvel’s Agent Carter,” “Marvel’s Daredevil,” "Lost").

"Marvel's Agents of S.H.I.E.L.D." is produced by Marvel Television and ABC Studios.

"Marvel's Agents of S.H.I.E.L.D." returns on Tuesday, March 3 at 9:00 p.m. ET on ABC. For more information on the series and the other exciting Marvel Television projects, stay tuned to Marvel.com.
Source: Marvel.

No comments:

Post a Comment